Related Experiment Video
Updated: Dec 25, 2025

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.6K
[Association between CD40-CD40L system and obesity in children]
1Children's Hospital of Zhejiang University School of Medicine, Hangzhou 310051, China. zcc14@zju.edu.cn.
Summary
The CD40-CD40L system is linked to childhood obesity, hyperlipidemia, and hypertension. These markers may help in early detection of metabolic syndrome and guide treatment strategies.
Area of Science:
- Pediatrics
- Immunology
- Metabolic Health
Background:
- Childhood obesity is a growing public health concern.
- The CD40-CD40L pathway plays a role in immune and inflammatory responses.
- Understanding the link between CD40-CD40L and obesity is crucial for metabolic health.
Purpose of the Study:
- To investigate the association between the CD40-CD40L system and obesity in children.
- To explore the relationship of CD40 and CD40L with clinical and biochemical parameters in obese children.
Main Methods:
- A case-control study involving 76 obese children and 74 healthy controls.
- Comparison of morphological indices, biochemical parameters, and serum CD40/CD40L levels.
- Statistical analyses including partial correlation and multivariate linear regression.
Main Results:
- Obese children showed significantly higher BMI, blood pressure, lipid profiles (except HDL), liver enzymes, uric acid, fasting glucose, insulin, HbA1c, platelets, and CD40L compared to controls.
- CD40L levels positively correlated with weight, BMI, blood pressure, and various lipid/biochemical markers.
- CD40 levels correlated with waist-height ratio and platelet count.
Conclusions:
- The CD40-CD40L system is significantly associated with childhood obesity, hyperlipidemia, and hypertension.
- CD40 and CD40L may serve as early warning indicators for metabolic syndrome.
- This research offers insights for preventing and managing related chronic diseases.
More Related Videos
Related Concept Videos
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
165
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
165
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
187
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
187
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
118
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
118
Overview of Lipid Metabolism
4.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.5K

